OSTEOGENESIS IMPERFECTA IN CHILDREN IN THE RUSSIAN FEDERATION: RESULTS OF THE FEDERAL REGISTRY AUDIT
https://doi.org/10.15690/pf.v13i1.1514
Abstract
Background: Development and maintenance of registries of patients with rare diseases helps to determine the prevalence thereof, assess quality of medical care rendering, develop possible ways of optimizing patient management and calculate the necessary budget.
Objective: Our aim was to study validity of including pediatric patients to the federal osteogenesis imperfecta registry and to determine disease characteristics, current or previous treatment.
Methods: We conducted a retrospective study of the data on patients with ost eogenesis imperfecta included in the federal registry of the Ministry of Health of Russia. We provide results of the first registry audit. We analyzed the clinical and laboratory data provided in the medical documentation.
Results: Validity of inclusion of patients with osteogenesis imperfecta in the registry was confirmed for 323 (96.4%) patients out of 335. In most cases (> 90%), bone fractures take place at the age of 6 months or later. Conclusion: It is reasonable to develop an electronic individual record form for patients with osteogenesis imperfecta for long-term monitoring of health condition and the conducted treatment.
About the Authors
G. T. YakhyayevaRussian Federation
Moscow
L. S. Namazova-Baranova
Russian Federation
Moscow
T. V. Margiyeva
Russian Federation
Moscow
O. V. Chumakova
Russian Federation
Moscow
References
1. Van Dijk FS, Sillence DO. Osteogenesis imperfecta: Clinical diagnosis, nomenclature and severity assessment. Am J Med Genet. 2014;164A:1470–1481.
2. URL: https://www.osteogenesisimperfecta.org/oir.html (Available: 14.01.2016).
3. Brennen CFS, Hart T, Huber MB, Headley H, Kantipuly A, Shapiro JR. Osteogenesis Imperfecta Foundation, Gaithersburg, MD USA, Punta Gorda, FL USA. The Osteogenesis Imperfecta Registry: An International Resource for Research. The 12th International Conference on Ostoegenesis Imperfecta. Abstract book. 2014.
4. URL: http://www.rarediseasesnetwork.org/cms/bbd/GetInvolved/ContactRegistry (Available: 14.01.2016).
5. Orioli IM, Castilla EE, Barbosa-Neto JG. The birth prevalence rates for the skeletal dysplasias. J Med Genet. 1986;23:328–332. doi: 10.1136/jmg.23.4.328.
6. Stoll C, Dott B, Roth MP, Alembik Y. Birth prevalence rates of skeletal dysplasias. Clin Genet. 1989;35:88–92. Doi: 10.1111/j.1399-0004.1989.tb02912.x.
7. Sillence DO, Senn A, Danks DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet. 1979;16: 101–116.
8. Andersen PE, Jr, Hauge M. Osteogenesis imperfecta: a genetic, radiological, and epidemiological study. Clin Genet. 1989; 36(4):250–255.
9. Martin E, Shapiro JR. Osteogenesis imperfecta: Epidemiology and pathophysiology. Curr Osteoporos Rep. 2007;5(Issue3): 91–97.
10. Kuurila K, Kaitila I, Johansson R, Grenman R. Hearing loss in Finnish adults with osteogenesis imperfecta: a nationwide survey. Ann Otol Rhinol Laryngol. 2002;111(10):939–946.
11. Harrington J, Sochett E, Howard A. Update on the evaluation and treatment of osteogenesis imperfecta. Pediatr Clin North Am. 2014;61(6):1243–1257. Doi: 10.1016/j.pcl.2014.08.010.
12. Biggin A, Munns CF. Osteogenesis imperfecta: diagnosis and treatment. Curr Osteoporos Rep. 2014;12(3):279–288. Doi: 10.1007/s11914-014-0225-0.
Review
For citations:
Yakhyayeva G.T., Namazova-Baranova L.S., Margiyeva T.V., Chumakova O.V. OSTEOGENESIS IMPERFECTA IN CHILDREN IN THE RUSSIAN FEDERATION: RESULTS OF THE FEDERAL REGISTRY AUDIT. Pediatric pharmacology. 2016;13(1):44-48. (In Russ.) https://doi.org/10.15690/pf.v13i1.1514